Entrada Therapeutics Inc (TRDA)
18.05
+0.12
(+0.67%)
USD |
NASDAQ |
Nov 21, 16:00
18.08
+0.02
(+0.14%)
After-Hours: 20:00
Entrada Therapeutics Price to Book Value: 1.601 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.588 |
| November 19, 2024 | 1.574 |
| November 18, 2024 | 1.546 |
| November 15, 2024 | 1.581 |
| November 14, 2024 | 1.686 |
| November 13, 2024 | 1.768 |
| November 12, 2024 | 1.753 |
| November 11, 2024 | 1.762 |
| November 08, 2024 | 1.756 |
| November 07, 2024 | 1.703 |
| November 06, 2024 | 1.653 |
| November 05, 2024 | 1.649 |
| November 04, 2024 | 1.574 |
| November 01, 2024 | 1.559 |
| October 31, 2024 | 1.518 |
| October 30, 2024 | 1.525 |
| October 29, 2024 | 1.530 |
| October 28, 2024 | 1.538 |
| October 25, 2024 | 1.504 |
| October 24, 2024 | 1.491 |
| October 23, 2024 | 1.502 |
| October 22, 2024 | 1.517 |
| October 21, 2024 | 1.533 |
| October 18, 2024 | 1.544 |
| October 17, 2024 | 1.561 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.564 |
| October 15, 2024 | 1.552 |
| October 14, 2024 | 1.578 |
| October 11, 2024 | 1.486 |
| October 10, 2024 | 1.400 |
| October 09, 2024 | 1.432 |
| October 08, 2024 | 1.451 |
| October 07, 2024 | 1.464 |
| October 04, 2024 | 1.511 |
| October 03, 2024 | 1.456 |
| October 02, 2024 | 1.442 |
| October 01, 2024 | 1.416 |
| September 30, 2024 | 1.415 |
| September 27, 2024 | 1.423 |
| September 26, 2024 | 1.364 |
| September 25, 2024 | 1.302 |
| September 24, 2024 | 1.332 |
| September 23, 2024 | 1.261 |
| September 20, 2024 | 1.270 |
| September 19, 2024 | 1.298 |
| September 18, 2024 | 1.181 |
| September 17, 2024 | 1.225 |
| September 16, 2024 | 1.259 |
| September 13, 2024 | 1.298 |
| September 12, 2024 | 1.286 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6208
Minimum
May 09 2022
3.069
Maximum
Oct 31 2022
1.767
Average
1.784
Median
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 3.812 |
| Vertex Pharmaceuticals Inc | 7.420 |
| Assembly Biosciences Inc | 3.615 |
| Sarepta Therapeutics Inc | 8.645 |
| Regenxbio Inc | 1.514 |
Price to Book Value Related Metrics
| PE Ratio | 11.37 |
| PS Ratio | 3.030 |
| Price | 18.05 |
| Earnings Yield | 8.80% |
| Market Cap | 676.37M |
| Operating PE Ratio | 11.28 |
| Normalized PE Ratio | 11.37 |